HKPD·G6365B104·US·equity·Healthcare - Pharmaceutical Retailers-Activist
SHS
HKPD (Cellyan Biotechnology Co., Ltd) is held by 3 institutional investors as of Q4 2025. Largest holders: TWO SIGMA INVESTMENTS, LP ($13,810), Clear Street Group Inc. ($9,908), UBS Group AG ($1,266). Net institutional sentiment: Bullish.
See how HKPD's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer